NZ515355A - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
NZ515355A
NZ515355A NZ515355A NZ51535500A NZ515355A NZ 515355 A NZ515355 A NZ 515355A NZ 515355 A NZ515355 A NZ 515355A NZ 51535500 A NZ51535500 A NZ 51535500A NZ 515355 A NZ515355 A NZ 515355A
Authority
NZ
New Zealand
Prior art keywords
alkyl
alkynyl
alkenyl
optionally substituted
ring
Prior art date
Application number
NZ515355A
Other languages
English (en)
Inventor
Puwen Zhang
Eugene A Terefenko
Horace Fletcher
Andrew Ensome
Jay E Wrobel
Lin Zhi
Todd K Jones
Keith B Arschke
Christopher M Tegley
Original Assignee
American Home Prod
Ligandpharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod, Ligandpharmaceuticals Inc filed Critical American Home Prod
Publication of NZ515355A publication Critical patent/NZ515355A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ515355A 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators NZ515355A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
NZ515355A true NZ515355A (en) 2004-02-27

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515355A NZ515355A (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (tr)
JP (1) JP2002543193A (tr)
KR (1) KR20010114250A (tr)
CN (1) CN1145618C (tr)
AU (1) AU766428B2 (tr)
BG (1) BG106079A (tr)
BR (1) BR0010213A (tr)
CA (1) CA2371726A1 (tr)
CZ (1) CZ20013951A3 (tr)
EA (1) EA004512B1 (tr)
HU (1) HUP0201609A3 (tr)
IL (1) IL146280A0 (tr)
MX (1) MXPA01011286A (tr)
NO (1) NO321361B1 (tr)
NZ (1) NZ515355A (tr)
PL (1) PL351127A1 (tr)
SG (1) SG114650A1 (tr)
SK (1) SK15912001A3 (tr)
TR (1) TR200103286T2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012402A (es) * 2004-04-27 2007-01-17 Wyeth Corp Carbamato y tiocarbamato biarilos ciclicos que contienen cianopirrol y metodos para preparar los mismos.
EP1844768A1 (en) * 2005-01-19 2007-10-17 Dainippon Sumitomo Pharma Co., Ltd. Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
NZ300739A (en) * 1994-12-22 2000-05-26 Ligand Pharm Inc Steroid receptor modulator compounds
AU4802797A (en) * 1996-10-02 1998-04-24 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv rever se transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
HUP0201609A3 (en) 2002-12-28
CA2371726A1 (en) 2000-11-09
EP1173426A1 (en) 2002-01-23
IL146280A0 (en) 2002-07-25
CN1349517A (zh) 2002-05-15
NO321361B1 (no) 2006-05-02
BR0010213A (pt) 2002-02-19
KR20010114250A (ko) 2001-12-31
AU4688600A (en) 2000-11-17
TR200103286T2 (tr) 2002-07-22
NO20015378L (no) 2002-01-03
BG106079A (en) 2002-05-31
EA200101176A1 (ru) 2002-04-25
SG114650A1 (en) 2005-09-28
MXPA01011286A (es) 2003-07-14
EA004512B1 (ru) 2004-04-29
NO20015378D0 (no) 2001-11-02
AU766428B2 (en) 2003-10-16
JP2002543193A (ja) 2002-12-17
HUP0201609A2 (en) 2002-08-28
CN1145618C (zh) 2004-04-14
CZ20013951A3 (cs) 2002-05-15
SK15912001A3 (sk) 2002-06-04
PL351127A1 (en) 2003-03-24

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
ATE194839T1 (de) Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AR035548A1 (es) Compuestos organicos
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
AR027402A1 (es) Derivados de pirimidina.
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
HUP9901096A2 (hu) Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
HUP0402640A2 (hu) Indolilalkilamin-származékok 5-hidroxitriptamin-6 ligandumokként, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
BG106080A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
NZ528997A (en) Sulfonamides
PE20020253A1 (es) Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos
DE69811556T2 (de) Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
NZ515351A (en) Thio-oxindole derivatives
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.
UY26448A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano -3 - benzazocinas sustituidas y su empleo como medicamentos.
DE59103080D1 (de) 9-Amino-2-phenylbicyclo[3.3.1]nonane und 9-Amino-2-phenylbicyclo[3.3.1]-non-2-ene und diese enthaltende therapeutische Mittel.
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: WYETH, US

Free format text: OLD OWNER(S): WYETH; LIGAND PHARMACEUTICALS INC.